AzTrials
AzTrials

Low Back PainOXYLOMNCT03055182

Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients

A study testing Physical rehabilitation program in people with Low Back Pain and Rehabilitation Program, run by University Hospital, Lille at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study evaluate paraspinal aerobic metabolism of chronic low back pain patients and healthy people during an original and standardized isokinetic protocol. The aim of this study is to determine a potential alteration of muscular aerobic metabolism in low back pain patients, in order to establish the underlying… Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
What is being tested?
Physical rehabilitation program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteFrance
Study dates
11 Jan 2017to 10 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • For Low back pain patients: suffering from low back pain for at least 3 month
  • For control subject: no back pain in the past year

Who cannot join

  • Chronic cardiovascular, pulmonary, metabolic, neurologic disease

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Swyngedhauw, CHRU

    Lille

Other trials in France

About this study

The study evaluate paraspinal aerobic metabolism of chronic low back pain patients and healthy people during an original and standardized isokinetic protocol.

The aim of this study is to determine a potential alteration of muscular aerobic metabolism in low back pain patients, in order to establish the underlying cause of pain and muscular fatigability characterizing low back pain patients. Then, the aim is to determine if functional rehabilitation program can improve it.

the unit of care have access to metabolic adaptations in measuring the muscular oxygenation and the pulmonary oxygen consumption, using near infrared spectroscopy and gas analyser.

Being tested
Physical rehabilitation program
Keywords
Isokinetic, oxygenation, deoxygenation, aerobic metabolism
Medical subject headings
Low Back Pain, Muscle Weakness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical rehabilitation programOther

    Patients participate during 4 weeks to a physical rehabilitation program.

Study groups in NCT03055182
Study groupRoleWhat they receive
Low back pain patientsExperimentalSubjects included in physical rehabilitation program.
Receives: Other: Physical rehabilitation program
Control subjectsNo interventionNo intervention administered

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Deoxyhemoglobin

    Expressed in arbitrary unit, at rest and during the isokinetic exercises (2 exercises of 5 minutes)

    Measured: 20 minutes

Secondary outcomes (6)
  1. Oxygen consumption

    Measured in mL/min/kg, at rest and during the isokinetic exercises (2 exercises of 5 minutes)

    Measured: 20 minutes

  2. Work rate

    Total work measured by the dynamometer in Joules during each exercises

    Measured: 10 minutes

  3. Rate of perceived exertion

    Bases on the Borg's Scale, evaluating the perceived exertion on a scale from 6 to 20

    Measured: 10 minutes

  4. Pain

    Bases on a visual analogic scale evaluating the pain on a scale from 0 to 10

    Measured: 10 minutes

  5. Muscular blood volume

    Expressed in arbitrary unit, at rest and during the isokinetic exercises (2 exercises of 5 minutes)

    Measured: 20 minutes

  6. Sorensen test

    test is a timed measure used to assess the endurance of the trunk extensor muscles. It is used to assist in the prediction of the incidence and occurrence of low back pain in patients.

    Measured: 20 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2017
  2. Study start11 Jan 2017
  3. Primary completion10 Dec 2024
  4. Study completion10 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03055182
Sponsor's protocol ID
2015_58
Other IDs
2016-A01151-50
Acronym
OXYLOM
Status last verified
Dec 2025
First submitted
7 Feb 2017
Last updated
23 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Physical rehabilitation program in people with Low Back Pain and Rehabilitation Program, run by University Hospital, Lille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Deoxyhemoglobin (time frame: 20 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in